July 30, 2014 11:03 PM ET

Healthcare Equipment and Supplies

Company Overview of Avinger, Inc.

Company Overview

Avinger, Inc., a medical device manufacturing company, develops catheter-based products for the treatment of peripheral artery disease (PAD). It offers Wildcat, a catheter for treating patients with PAD; Kittycat 2, a support catheter; Juicebox, a battery-powered accessory that automatically rotates the distal tip of catheters; and Ocelot, an interventional chronic total occlusion crossing catheter to navigate and cross totally blocked arteries in the legs of patients suffering from PAD. The company also provides medical management, bypass, amputation, and endovascular procedures for patients in the United States. In addition, it markets Kittycat guidewire support catheters; and develops tec...

400 Chesapeake Drive

Redwood City, CA 94063

United States

Founded in 2007

Phone:

800-208-2988

Fax:

800-229-2696

Key Executives for Avinger, Inc.

Founder
Age: 70
Chief Medical Officer
Chief Business Officer
Age: 46
Chief Operating Officer
Chief Technology Officer
Compensation as of Fiscal Year 2014.

Avinger, Inc. Key Developments

Avinger, Inc. Presents at 8th Annual JMP Securities Healthcare Conference, Jul-09-2013 01:00 PM

Avinger, Inc. Presents at 8th Annual JMP Securities Healthcare Conference, Jul-09-2013 01:00 PM. Venue: The St. Regis Hotel, 2 East 55th Street, New York, NY 10022, United States.

Avinger, Inc. Completes Mezzanine Financing with PDL Biopharma

Avinger, Inc., and PDL BioPharma, Inc. announced the closing of a structured financing and royalty transaction on April 18, 2013, in which PDL will provide Avinger with up to $40 million of mezzanine financing. PDL is providing $20 million at closing and up to an additional $20 million upon achievement of certain future revenue milestones. In exchange, PDL will receive interest on the principal amount outstanding and a low, single-digit royalty on Avinger's revenues through April 2018. The funds will be used to support the continued commercialization of Avinger's lumivascular technologies, which currently consist of the Ocelot family of products and Lightbox, and further development of Pantheris(TM), the company's next-generation lumivascular atherectomy device. Lumivascular procedures employ a catheter system that incorporates light-based, radiation-free, intravascular imaging technology within the actual interventional device. This provides physicians with live, real-time, video-rate images of the inside of an artery during treatment, offering a variety of benefits for patients, physicians and hospitals.

PDL BioPharma, Inc. to Provide Avinger, Inc. Up to $40 Million of Mezzanine Financing

Avinger, Inc. and PDL BioPharma, Inc. announced the closing of a structured financing and royalty transaction on April 18, 2013, in which PDL will provide Avinger with up to $40 million of mezzanine financing. PDL is providing $20 million at closing and up to an additional $20 million upon achievement of certain future revenue milestones. In exchange, PDL will receive interest on the principal amount outstanding and a low, single-digit royalty on Avinger's revenues through April 2018. The funds will be used to support the continued commercialization of Avinger's lumivascular technologies, which currently consist of the Ocelot family of products and Lightbox, and further development of Pantheris(TM), the company's next-generation lumivascular atherectomy device.

Similar Private Companies By Industry

Company Name Region
Quantum Designs, LLC United States
BASIC Dental Implant Systems, Inc. United States
Kinova USA, LLC United States
Mediaid, Inc. United States
Inceptus Medical LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
October 29, 2013
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Avinger, Inc., please visit www.avinger.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.